![Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures - Ye - 2016 - Human Brain Mapping - Wiley Online Library Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures - Ye - 2016 - Human Brain Mapping - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/968f4beb-9d92-4bd6-bc05-84c88ba9e51d/hbm.v37.3.cover.jpg?trick=1674317734445)
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures - Ye - 2016 - Human Brain Mapping - Wiley Online Library
![Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41398-020-01097-6/MediaObjects/41398_2020_1097_Fig1_HTML.png)
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry
![Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41398-019-0507-5/MediaObjects/41398_2019_507_Fig1_HTML.png)
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry
![Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41398-019-0507-5/MediaObjects/41398_2019_507_Fig3_HTML.png)
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry
![These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998 These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=citalopram-tablets-usp-3.jpg&id=635719)
These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998
![PDF) Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients PDF) Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients](https://i1.rgstatic.net/publication/334240871_Metabolomic_signature_of_exposure_and_response_to_citalopramescitalopram_in_depressed_outpatients/links/5d1ece74458515c11c1296cc/largepreview.png)
PDF) Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
![Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior | Translational Psychiatry Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior | Translational Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41398-019-0466-x/MediaObjects/41398_2019_466_Fig1_HTML.png)